Pr. Francis Berenbaum, 4Moving Biotech’s co-founder, CMO, and former OARSI chairman, has presented at OARSI World Congress on Osteoarthritis our latest developments in the study of OA, from March 16 to 20, 2023, in Denver, USA.

Pr. Francis Berenbaum showcased two posters of the OARSI congress.

First poster at OA clinical trial symposium from March 16, 2023‍

Poster title: GLP1 analogues as a potential DMOAD: why, how, when?

The second Poster was a keynote presented during the OA research plenary session on March 17, 2023. ‍

Poster title: Have We Been Driving in the Wrong Lane? Pivoting from Past Setbacks to Future Therapeutic Successes

‍

‍